| Literature DB >> 7022854 |
P Sweny, K Farrington, F Younis, Z Varghese, R A Baillod, O N Fernando, J F Moorhead.
Abstract
CY-A is a potent immunosuppressive agent and can prevent graft rejection. In our experience hirsutism and viral infections are marked. Lymphomas may be more common in CY-A-treated patients than in those treated conventionally. Smaller doses of CY-A given for shorter periods before conversion to conventional treatment may be a better way to use this new agent.Entities:
Mesh：
Substances：
Year: 1981 PMID： 7022854
Source DB: PubMed Journal: Transplant Proc ISSN： 0041-1345 Impact factor: 1.066